Respiratory Disorders in Systemic Sclerosis

Authors

  • Pasakorn Jitruckthai Department of Internal Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University
  • Emvalee Arromdee Department of Internal Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University
  • Suree Sompradeekul Department of Internal Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University

Keywords:

Pulmonary hypertension, respiratory disorders, systemic sclerosis

Abstract

Respiratory disorders in systemic sclerosis (SSc) are common. They are also a leading cause of morbidity and mortality in this group of patients. Currently, there are no good clinical or serological parameters that would predict respiratory disorders in SSc. The aims of this study are to review the different patterns of respiratory disorder in Thai SSc and to identify the clinical and serological parameters that may be associated with those respiratory disorders. A retrospective medical records review was performed. Out of 137 scleroderma patients seen by the division of rheumatology at Siriraj Hospital Mahidol University from January 1986 to December 2006, sixty-six (48.2%) had respiratory disorders. The most common respiratory disorder was interstitial lung disease (ILD) (81.8%), followed by secondary pulmonary hypertension (PHT) (24%). A few cases of isolated PHT were found (3%). There were no statistically significant differences in the clinical manifestations, disease subtypes or serological parameters between SSc patients who had ILD with or without secondary PHT. Raynaudûs phenomenon was very commonly seen in the SSc patients with PHT.Â

 

Downloads

Published

01-03-2008

How to Cite

Jitruckthai, P. ., Arromdee, E. ., & Sompradeekul, S. . (2008). Respiratory Disorders in Systemic Sclerosis. Siriraj Medical Journal, 60(2), 74–77. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/246360

Issue

Vol. 60 No. 2 (2008): Mar-Apr

Section

Original Article

License

Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:

  • Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.